https://www.selleckchem.com/pr....oducts/tocilizumab.h
Longitudinal studies assessing depression and anxiety effects on cognition in multiple sclerosis (MS) are limited. We tested whether within-person fluctuations in symptoms of depression or anxiety over time affect cognition in persons with MS, inflammatory bowel disease (IBD), rheumatoid arthritis (RA), and a lifetime history of depression/anxiety disorders (DEP/ANX) but without an immune-mediated inflammatory diseases (IMID). We followed participants (MS 255, IBD 247, RA 154, and DEP/ANX 306) for 3 years. Annually, they completed t
Like
Comment
Share
